Early Detection, Risk Stratification, and Drug Target Identification in Pulmonary Arterial Hypertension with Plasma Proteomics

Early Detection, Risk Stratification, and Drug Target Identification in Pulmonary Arterial Hypertension with Plasma Proteomics

Pulmonary arterial hypertension is a rare condition that is clinically heterogenous and often diagnosed late in disease progression. Plasma proteomics offers the potential to diagnose earlier, risk-stratify patients, and identify new drug targets.

Learning Objectives

  • Pulmonary arterial hypertension as a clinical condition
  • Applying proteomics to risk stratification
  • Combining proteomics with genome-wide association studies to identify protein quantitative trait loci associated with the condition

Christopher Rhodes, MA, Cantab, PhD

Christopher Rhodes, MA, Cantab, PhD

Senior British Heart Foundation Science Fellow
Senior Lecturer
Imperial College London

Martin R. Wilkins

Martin R. Wilkins

Professor of Clinical Pharmacology
Vice Dean of Research
Faculty of Medicine
Imperial College London

Early Detection, Risk Stratification, and Drug Target Identification in Pulmonary Arterial Hypertension with Plasma Proteomics

A presentation by Christopher Rhodes, MA, Cantab, PhD, and Martin R. Wilkins

Share with colleagues

More webinars

WebinarCorrelation of a Nonalcoholic Steatohepatitis Proteomic Test with Clinical Outcomes

In this webinar, Anne Minnich, PhD, biomarker consultant at Bristol Myers Squibb, presents research on the use of the new SomaSignal(TM) NASH bundle test in a recently completed clinical trial.

Learn more

WebinarHarnessing AI and proteomics for glioblastoma

The development and advancement of aptamer technology opens vast possibilities for unlocking the biocomplexity available within proteomics. Learn more about the powerful tools that are enabling the discovery and validation of clinically relevant biomarkers and accelerating research.

Learn more

WebinarMapping the human mucosal immune response to respiratory viruses

Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.

Learn more